본문으로 건너뛰기
← 뒤로

Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.

단면연구 1/5 보강
Cancer management and research 2025 Vol.17() p. 3073-3085
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
261 patients with CRC receiving chemotherapy across five tertiary care hospitals in Shanghai, selected through convenience sampling.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] This study is among the first to apply network analysis to chemotherapy-related symptom interactions and potential mechanisms in CRC, highlighting central targets for intervention. These findings may inform more precise and efficient symptom management approaches in oncology care.

Xie R, Gu XX, Wang Y

📝 환자 설명용 한 줄

[OBJECTIVE] This study aimed to construct a symptom network in patients diagnosed with colorectal cancer (CRC) undergoing chemotherapy, thereby providing a theoretical framework for optimizing symptom

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 연구 설계 cross-sectional

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Xie R, Gu XX, Wang Y (2025). Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.. Cancer management and research, 17, 3073-3085. https://doi.org/10.2147/CMAR.S558889
MLA Xie R, et al.. "Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.." Cancer management and research, vol. 17, 2025, pp. 3073-3085.
PMID 41393251

Abstract

[OBJECTIVE] This study aimed to construct a symptom network in patients diagnosed with colorectal cancer (CRC) undergoing chemotherapy, thereby providing a theoretical framework for optimizing symptom management strategies.

[METHODS] A cross-sectional survey was conducted among 261 patients with CRC receiving chemotherapy across five tertiary care hospitals in Shanghai, selected through convenience sampling. Network analysis was applied to construct the symptom network and to determine centrality indices, including strength centrality. Model accuracy and stability were evaluated using nonparametric bootstrapping techniques.

[RESULTS] Symptom prevalence ranged from 5.4% to 85.8%, with severity scores ranging from 0.51±1.44 to 4.83±3.23. Fatigue was associated with the highest severity score. Depression ( = 2.188), nausea ( = 1.290), and anorexia ( = 1.223) demonstrated the highest strength centrality values. The constructed network model exhibited high accuracy and stability, as indicated by narrow confidence intervals and Correlation Stability (CS) coefficients exceeding 0.25.

[CONCLUSION] This study is among the first to apply network analysis to chemotherapy-related symptom interactions and potential mechanisms in CRC, highlighting central targets for intervention. These findings may inform more precise and efficient symptom management approaches in oncology care.

같은 제1저자의 인용 많은 논문 (5)